TCW Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-21,050
Closed -$1.69M 689
2016
Q4
$1.69M Hold
21,050
0.01% 390
2016
Q3
$1.68M Buy
21,050
+200
+1% +$16.1K 0.01% 374
2016
Q2
$1.63M Sell
20,850
-4,900
-19% -$349K 0.01% 377
2016
Q1
$1.42M Sell
25,750
-2,000
-7% -$109K 0.01% 411
2015
Q4
$1.71M Sell
27,750
-700
-2% -$44.1K 0.01% 388
2015
Q3
$1.79M Sell
28,450
-2,200
-7% -$157K 0.01% 370
2015
Q2
$2.24M Sell
30,650
-60,400
-66% -$4.36M 0.01% 374
2015
Q1
$5.96M Buy
91,050
+1,050
+1% +$69.8K 0.03% 358
2014
Q4
$5.85M Sell
90,000
-58,600
-39% -$3.77M 0.02% 367
2014
Q3
$8.94M Sell
148,600
-2,900
-2% -$189K 0.04% 347
2014
Q2
$10.5M Buy
151,500
+10,550
+7% +$684K 0.04% 327
2014
Q1
$9.22M Sell
140,950
-3,350
-2% -$218K 0.04% 346
2013
Q4
$8.94M Buy
144,300
+2,550
+2% +$148K 0.04% 352
2013
Q3
$7.6M Buy
141,750
+2,800
+2% +$144K 0.04% 375
2013
Q2
$6.34M Buy
+138,950
New +$6.02M 0.03% 418

Other funds holding STJ

TCW Group's STJ Position: Q1 2017 in Review

TCW Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 21,050 shares — an estimated $1.69M sold.

TCW Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $10.5M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • TCW Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • TCW Group sold 21,050 St Jude Medical shares in Q1 2017, an estimated $1.69M.
  • TCW Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • TCW Group's St Jude Medical position peaked at $10.5M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on TCW Group's 13F filing for Q1 2017, filed 12 May 2017.